摘要
目的：研究参松养心胶囊与美托洛尔缓释片联合方案治疗冠心病心律失常的临床疗效。方法：选取2011年3月～2014年3月于本院进行治疗的92例冠心病心律失常患者，分为对照组46例和观察组46例，对照组患者在常规治疗基础上给予美托洛尔进行治疗，观察组患者在对照组基础上给予参松养心胶囊进行治疗，对比观察2组患者的临床疗效。结果：对照组46例患者的总有效率为73．91％，观察组46例患者的总有效率为91．30％，观察组的临床疗效明显优于对照组，P＜0．05，差异具有统计学意义。结论：参松养心胶囊与美托洛尔缓释片联合方案治疗冠心病心律失常的临床疗效显著，值得临床推广应用。
Objective：To investigate the curative effect of Shensongyangxin capsule and sustained release tablets of metoprolol com-bined regimen in the treatment of coronary heart disease with arrhythmia.Methods：From 2011 March to 2014 March,92 cases of arrhyth-mia in coronary heart disease patients treated in our hospital , were divided into the control group 46cases and observation group 46 cases, control group given metoprolol for treatment on the basis of the conventional treatment , observation group based on the control group given Shensongyangxin capsule for treatment,observed the clinical efficacy of the two groups .Rseults：46 cases in the control group the total ef-ficiency is 73.91%, the observation group of 46 cases with the total effective rate was 91.30%, clinical curative effect is obviously better than the observation group in the control group, P〈0.05, the difference was statistically significant.Conclusion：The therapeutic effect of Shensongyangxin capsule and sustained release tablets of metoprolol combined regimen in the treatment of arrhythmia in coronary heart dis-ease is significant, worthy of clinical application.
出处
《中国伤残医学》
2015年第7期10-11,共2页
Chinese Journal of Trauma and Disability Medicine
关键词
参松养心胶囊
美托洛尔缓释片
联合方案
冠心病
心律失常
药物疗法
Shensongyangxin capsule
Metoprolol sustained-release tablets
Coronary heart disease
Arrhythmia
Drug therapy
